Oakworth Capital’s Bristol-Myers Squibb BMY Stock Holding History

Oakworth Capital’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$599K	Sell	10,513 -133	-1%	-$7.64K	0.03%	135
2026 Q1	$646K	Buy	10,646 +500	+5%	+$29.1K	0.03%	125
2025 Q4	$547K	Hold	10,146	–	–	0.03%	129
2025 Q3	$458K	Buy	10,146 +4,658	+85%	+$218K	0.03%	141
2025 Q2	$254K	Sell	5,488 -611	-10%	-$30K	0.02%	187
2025 Q1	$372K	Buy	6,099 +563	+10%	+$32.8K	0.03%	143
2024 Q4	$313K	Sell	5,536 -1,952	-26%	-$109K	0.02%	160
2024 Q3	$387K	Sell	7,488 -149	-2%	-$6.99K	0.03%	144
2024 Q2	$317K	Buy	7,637 +115	+2%	+$5.15K	0.02%	151
2024 Q1	$408K	Sell	7,522 -1,843	-20%	-$93.9K	0.03%	134
2023 Q4	$481K	Sell	9,365 -91	-1%	-$4.78K	0.04%	119
2023 Q3	$549K	Sell	9,456 -185	-2%	-$11.3K	0.05%	96
2023 Q2	$617K	Sell	9,641 -346	-3%	-$23.2K	0.05%	93
2023 Q1	$692K	Sell	9,987 -474	-5%	-$33.4K	0.06%	84
2022 Q4	$753K	Sell	10,461 -1,190	-10%	-$89.7K	0.07%	71
2022 Q3	$828K	Hold	11,651	–	–	0.09%	68
2022 Q2	$897K	Sell	11,651 -165	-1%	-$12.6K	0.09%	69
2022 Q1	$863K	Buy	11,816 +1,141	+11%	+$76.6K	0.07%	80
2021 Q4	$666K	Buy	10,675 +27	+0.3%	+$1.58K	0.06%	89
2021 Q3	$630K	Sell	10,648 -427	-4%	-$28.1K	0.06%	93
2021 Q2	$740K	Sell	11,075 -846	-7%	-$55.2K	0.07%	81
2021 Q1	$753K	Buy	11,921 +1,111	+10%	+$69.1K	0.09%	76
2020 Q4	$671K	Sell	10,810 -934	-8%	-$57.4K	0.09%	76
2020 Q3	$708K	Hold	11,744	–	–	0.11%	65
2020 Q2	$690K	Buy	11,744 +4,173	+55%	+$250K	0.12%	67
2020 Q1	$422K	Sell	7,571 -390	-5%	-$23.8K	0.1%	77
2019 Q4	$508K	Buy	7,961 +217	+3%	+$12.4K	0.09%	85
2019 Q3	$393K	Sell	7,744 -4,389	-36%	-$206K	0.08%	94
2019 Q2	$550K	Sell	12,133 -49	-0.4%	-$2.28K	0.1%	84
2019 Q1	$581K	Hold	12,182	–	–	0.12%	79
2018 Q4	$633K	Buy	12,182 +1,856	+18%	+$99.7K	0.14%	66
2018 Q3	$641K	Buy	10,326 +331	+3%	+$19.6K	0.13%	73
2018 Q2	$554K	Buy	9,995 +1,005	+11%	+$54.3K	0.12%	79
2018 Q1	$469K	Sell	8,990 -1,686	-16%	-$108K	0.11%	85
2017 Q4	$675K	Sell	10,676 -573	-5%	-$35.8K	0.16%	66
2017 Q3	$680K	Buy	11,249 +200	+2%	+$11.7K	0.17%	66
2017 Q2	$616K	Buy	11,049 +219	+2%	+$11.9K	0.17%	66
2017 Q1	$589K	Buy	10,830 +385	+4%	+$21.1K	0.17%	68
2016 Q4	$589K	Buy	10,445 +820	+9%	+$44.8K	0.19%	69
2016 Q3	$519K	Buy	9,625 +43	+0.4%	+$2.76K	0.18%	73
2016 Q2	$687K	Hold	9,582	–	–	0.26%	60
2016 Q1	$612K	Buy	9,582 +1,360	+17%	+$85.8K	0.24%	62
2015 Q4	$565K	Buy	8,222 +7,276	+769%	+$481K	0.24%	65
2015 Q3	$56K	Hold	946	–	–	0.03%	142
2015 Q2	$62K	Hold	946	–	–	0.03%	142
2015 Q1	$60K	Hold	946	–	–	0.03%	174
2014 Q4	$56K	Buy	946 +47	+5%	+$2.65K	0.03%	170
2014 Q3	$46K	Hold	899	–	–	0.03%	142
2014 Q2	$44K	Hold	899	–	–	0.03%	144
2014 Q1	$47K	Hold	899	–	–	0.03%	136
2013 Q4	$48K	Buy	+899	New	+$45.8K	0.03%	125

Other funds holding BMY

LMFP

Larry Mathis Financial Planning Phoenix, Arizona $124B AUM

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

AIM

Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

FWIA

Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

DLA

Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Oakworth Capital's BMY Position: Q2 2026 in Review

Oakworth Capital reduced its Bristol-Myers Squibb (BMY) stake by 1.2% in Q2 2026, selling an estimated $7.64K and leaving 10,513 shares worth $599K. The position accounts for 0.03% of the portfolio, ranked #135.

Oakworth Capital first reported a position in BMY in Q4 2013 and has held it in 51 quarters since. The position peaked at $897K in Q2 2022. 796 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

Oakworth Capital held 10,513 shares of Bristol-Myers Squibb worth $599K as of Q2 2026.
Oakworth Capital sold 133 Bristol-Myers Squibb shares in Q2 2026, an estimated $7.64K.
Bristol-Myers Squibb made up 0.03% of Oakworth Capital's portfolio in Q2 2026, its #135 holding.
Oakworth Capital first reported a position in Bristol-Myers Squibb in Q4 2013 and has held it in 51 quarters since.
Oakworth Capital's Bristol-Myers Squibb position peaked at $897K in Q2 2022.
796 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Oakworth Capital's 13F filing for Q2 2026, filed 22 Jul 2026.